Crossmark

Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATE

Crossref DOI link: https://doi.org/10.1007/s00259-016-3533-z

Published Online: 2016-10-04

Published Print: 2017-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sansovini, Maddalena

Severi, Stefano

Ianniello, Annarita

Nicolini, Silvia

Fantini, Lorenzo

Mezzenga, Emilio

Ferroni, Fabio

Scarpi, Emanuela

Monti, Manuela

Bongiovanni, Alberto

Cingarlini, Sara

Grana, Chiara Maria

Bodei, Lisa

Paganelli, Giovanni
License Information

License valid from 2016-10-04